Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract [clinicaltrials:NCT00002914]
Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract [clinicaltrials:NCT00002914]
Bio2RDF identifier
NCT00002914
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00002914
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... ponded to previous treatment.
brief title [clinicaltrials_vocabulary:brief-title]
Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2004-03-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Evaluate ...... first 14 evaluable patients.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
adenocarcinoma of the bladder
recurrent bladder cancer
recurrent transitional cell cancer of the renal pelvis and ureter
recurrent urethral cancer
squamous cell carcinoma of the bladder
transitional cell carcinoma of the bladder
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2010-01-25T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00002914
official title [clinicaltrials_vocabulary:official-title]
PHASE II STUDY OF PIRITREXIM IN ADVANCED CARCINOMA OF THE UROTHELIUM
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000065289
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2001-06-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1997-05-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2010-01-01T00:00:00Z
identifier
clinicaltrials:NCT00002914
title
Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract
@en
type
label
Piritrexim in Treating Patient ...... t [clinicaltrials:NCT00002914]
@en